You are here

diabetes

Biocon and Mylan Launch Semglee; Biosimilar, Interchangeable Status Are Sought

Center for Biosimilars

Tue, 09/1/20 - 10:44 am

ESC 2020 – Farxiga impresses in chronic kidney disease

EP Vantage

Mon, 08/31/20 - 10:14 am

chronic kidney disease

clinical trials

Study: Type 2 Diabetes Treatments May Be More Effective When Combined

BioSpace

Sun, 08/30/20 - 11:27 pm

type 2 diabetes

FDA pulls J&J's Invokana boxed warning after reviewing amputation risks—but the sales damage is done

Fierce Pharma

Thu, 08/27/20 - 10:15 pm

Novo Nordisk: Prevention, digital tools and collaboration to define the future of diabetes

Pharmaforum

Tue, 08/11/20 - 11:38 am

digital medicine

25% of diabetes patients rationing treatments amid pandemic, survey finds

Beckers Hospital Review

Sun, 08/2/20 - 11:28 pm

Boehringer and Lilly’s Jardiance Hits Mark in Decreasing Risk of Death in Heart Failure

BioSpace

Fri, 07/31/20 - 10:40 am

Boehringer Ingelheim

clinical trials

Drug lobby sues Minnesota over insulin-pricing law

Beckers Hospital Review

Thu, 07/2/20 - 11:07 am

FDA urged to increase safety warnings on common diabetes drug

Beckers Hospital Review

Thu, 06/25/20 - 10:48 am

citizen petitions

SGLT2 inhibitor

type 1 diabetes

Mylan, seeking to market Victoza generic, convinces panel to start up patent review

Fierce Pharma

Wed, 06/24/20 - 11:18 pm

Novaremed gets FDA nod for phase 2 trial of NRD135S.E1 for PDPN

Pharmaceutical Business Review

Wed, 06/24/20 - 10:21 am

clinical trials

painful diabetic peripheral neuropathy

Evoke Pharma finally lands approval for lead and only drug

Endpoints

Mon, 06/22/20 - 11:09 am

diabetic gastroparesis

Study: Pfizer's Experimental Diabetes Drug Robustly Reduces Weight and Glucose

BioSpace

Tue, 06/16/20 - 07:02 pm

ADA: Merck, Pfizer's Steglatro rings up CV safety win but still lags heart-helping peers

Fierce Pharma

Tue, 06/16/20 - 06:59 pm

ADA: AstraZeneca's diabetes-fighter Farxiga cuts risk of fast decline in kidney function

Fierce Pharma

Mon, 06/15/20 - 11:10 pm

chronic kidney disease

Why MannKind Stock Crushed it Monday

Motley Fool

Mon, 06/15/20 - 11:03 pm

inhaled insulin

Abbott's Bluetooth-Enabled Glucose Monitor Finally Clears FDA Hurdle

Motley Fool

Mon, 06/15/20 - 10:36 am

blood glucose monitoring

Freestyle Libre 2

ADA: Lilly's Trulicity tops Ozempic at keeping patients compliant, real-world data show

Fierce Pharma

Sun, 06/14/20 - 08:14 pm

ADA: Sanofi bolsters Soliqua with real-world data showing starting insulin, GLP-1 together helps control blood sugar

Fierce Pharma

Sun, 06/14/20 - 08:06 pm

type 2 diabetes

ADA: Novo Nordisk's long-lasting insulin candidate matches Lantus in phase 2

Fierce Pharma

Sun, 06/14/20 - 08:05 pm

Pages